Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $127.90 USD
Change Today +0.94 / 0.74%
Volume 675.0K
IDXX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

idexx laboratories inc (IDXX) Snapshot

Open
$131.82
Previous Close
$126.96
Day High
$133.65
Day Low
$126.44
52 Week High
01/23/15 - $168.51
52 Week Low
09/23/14 - $113.49
Market Cap
6.0B
Average Volume 10 Days
973.7K
EPS TTM
$3.83
Shares Outstanding
46.8M
EX-Date
--
P/E TM
33.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for IDEXX LABORATORIES INC (IDXX)

idexx laboratories inc (IDXX) Related Bloomberg News

View More Bloomberg News

idexx laboratories inc (IDXX) Related Businessweek News

No Related Businessweek News Found

idexx laboratories inc (IDXX) Details

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems for veterinarians; and biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic, health-monitoring, and food safety testing products for livestock, poultry, and dairy; products that test water for certain microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company sells its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

6,400 Employees
Last Reported Date: 02/17/15
Founded in 1983

idexx laboratories inc (IDXX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $800.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $496.2K
Executive Vice President
Total Annual Compensation: $416.9K
Executive Vice President
Total Annual Compensation: $416.9K
Executive Vice President
Total Annual Compensation: $416.9K
Compensation as of Fiscal Year 2014.

idexx laboratories inc (IDXX) Key Developments

IDEXX Laboratories, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter and Full Year 2015

IDEXX Laboratories, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of $382,477,000 against $360,203,000 a year ago. Income from operations was $72,803,000 against $70,046,000 a year ago. Income before provision for income taxes was $66,924,000 against $67,743,000 a year ago. Net income attributable to stockholders was $46,594,000 or $0.98 per diluted share against $46,585,000 or $0.89 per diluted share a year ago. Net cash used in operating activities was $14,644,000 against net cash provided by operating activities of $33,518,000 a year ago. Purchases of property and equipment were $23,017,000 against $11,298,000 a year ago. Foreign exchange was a significant headwind in first quarter, resulting in a 6% year-on-year reduction in reported growth. These changes reduced year-on-year operating profit by over $5 million or about $0.01 per share more than originally projected. Results were supported by strong organic growth and better-than-expected operating margins. For the second quarter of 2015, the company expects a normalized organic revenue growth to be relatively consistent with first quarter with operating margins down 50 to 100 basis points compared to the prior year, reflecting timing of spending and FX impacts. The company expects organic revenue growth rates to improve as they work through the year, reflecting the benefit and the maturation of expanded direct commercial organization in the U.S. and the rollout of new product introductions, including T4 addition to Catalyst profile and the additions of SDMA and fecal antigen into reference laboratory offering in the second half. The company is updating its 2015 financial guidance to reflect expectations for 12% to 13% normalized organic revenue growth and to reflect additional strengthening of the US dollar relative to foreign currencies. The company is also updating its free cash flow forecast to reflect expectations for higher capital spending in support of business growth. Revenue expected to be $1,600 million to $1,620 million, EPS expected to be $4.14 to $4.24, free cash flow expected to 80% to 90% of net income, capital expenditures expected to be $100 million, effective tax rate expected to be 30% and interest expense, net of interest income, of approximately $28 million reflecting current and projected borrowings.

IDEXX Laboratories, Inc. to Report Q1, 2015 Results on Apr 28, 2015

IDEXX Laboratories, Inc. announced that they will report Q1, 2015 results at 8:30 AM, US Eastern Standard Time on Apr 28, 2015

IDEXX Laboratories, Inc., Q1 2015 Earnings Call, Apr 28, 2015

IDEXX Laboratories, Inc., Q1 2015 Earnings Call, Apr 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDXX:US $127.90 USD +0.94

IDXX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr203.50 SEK +0.30
MEDNAX Inc $70.43 USD -0.79
PerkinElmer Inc $50.30 USD -0.91
Sirona Dental Systems Inc $93.37 USD -1.22
Teleflex Inc $122.71 USD -0.33
View Industry Companies
 

Industry Analysis

IDXX

Industry Average

Valuation IDXX Industry Range
Price/Earnings 34.6x
Price/Sales 4.0x
Price/Book 174.6x
Price/Cash Flow 32.7x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDEXX LABORATORIES INC, please visit www.idexx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.